• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA SNHG12 通过调控 wnt/β-连环蛋白信号通路促进甲状腺乳头状癌细胞的增殖和转移。

LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.

机构信息

Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China.

Department of Nuclear Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China.

出版信息

Cancer Biomark. 2018;22(2):217-226. doi: 10.3233/CBM-170777.

DOI:10.3233/CBM-170777
PMID:29630517
Abstract

OBJECTIVE

To investigate the expression and role of long non-coding RNA (lncRNA) small nucleolar RNA host gene 12 (SNHG12) in papillary thyroid carcinoma (PTC).

METHODS

The relative expression levels of lncRNA SNHG12 (hereinafter referred to as SNHG12) in 42 pairs of PTC tissues and para-carcinoma tissues were detected via quantitative reverse transcription polymerase chain reaction (qRT-PCR). SNHG12 specific interference sequences were designed and synthesized. The relative expression level and transfection efficiency of SNHG12 in PTC cells were detected via qRT-PCR. After the interference in SNHG12 expression, the change in cell proliferation capacity was detected via methyl thiazolyl tetrazolium (MTT) assay, the change in cell cycle distribution was detected via flow cytometry, the changes in cell migration and invasion capacities were detected via Transwell assay and wound healing assay, and the changes in expressions of molecular markers of Wnt/β-catenin pathway were detected via Western blotting. The pulmonary metastasis model of nude mice was established, and the changes in migration and invasion capacities of tumor cells were studied via the in-vivo experiment after the interference in SNHG12 expression.

RESULTS

The results of qRT-PCR showed that the SNHG12 expression was up-regulated in 30 pairs of PTC tissues and cells. The results of MTT assay showed that the cell proliferation capacity was inhibited after the interference in SNHG12. The results of flow cytometry showed that the cell cycle progression was blocked in G1-G0 phase after the knockdown of SNHG12 expression. The results of Transwell assay and Western blotting showed that the interference in SNHG12 could inhibit the invasion and metastasis capacities of tumor cells through influencing the Wnt/β-catenin signaling pathway. Metastatic tumor model of nude mice showed that SNHG12 could affect the invasion and metastasis of tumor cells in vivo.

CONCLUSION

The SNHG12 expression is relatively high in PTC tissues and cells. In-vivo/in-vitro experiments prove that SNHG12 can promote the proliferation and metastasis of PTC cells through influencing the Wnt/β-catenin signaling pathway.

摘要

目的

研究长链非编码 RNA(lncRNA)小核仁 RNA 宿主基因 12(SNHG12)在甲状腺乳头状癌(PTC)中的表达和作用。

方法

通过实时荧光定量聚合酶链反应(qRT-PCR)检测 42 对 PTC 组织和癌旁组织中 lncRNA SNHG12(以下简称 SNHG12)的相对表达水平。设计并合成 SNHG12 特异性干扰序列。通过 qRT-PCR 检测 PTC 细胞中 SNHG12 的相对表达水平和转染效率。干扰 SNHG12 表达后,通过噻唑蓝(MTT)比色法检测细胞增殖能力的变化,通过流式细胞术检测细胞周期分布的变化,通过 Transwell 实验和划痕愈合实验检测细胞迁移和侵袭能力的变化,通过 Western blot 检测 Wnt/β-catenin 通路分子标志物表达的变化。建立裸鼠肺转移模型,通过体内实验研究干扰 SNHG12 表达后肿瘤细胞迁移和侵袭能力的变化。

结果

qRT-PCR 结果显示,30 对 PTC 组织和细胞中 SNHG12 表达上调。MTT 检测结果显示,干扰 SNHG12 后细胞增殖能力受到抑制。流式细胞术结果显示,下调 SNHG12 表达后细胞周期阻滞于 G1-G0 期。Transwell 实验和 Western blot 结果显示,干扰 SNHG12 可通过影响 Wnt/β-catenin 信号通路抑制肿瘤细胞的侵袭和转移能力。裸鼠转移瘤模型显示,SNHG12 可影响肿瘤细胞在体内的侵袭和转移。

结论

SNHG12 在 PTC 组织和细胞中表达较高。体内/体外实验证明,SNHG12 可通过影响 Wnt/β-catenin 信号通路促进 PTC 细胞的增殖和转移。

相似文献

1
LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.长链非编码 RNA SNHG12 通过调控 wnt/β-连环蛋白信号通路促进甲状腺乳头状癌细胞的增殖和转移。
Cancer Biomark. 2018;22(2):217-226. doi: 10.3233/CBM-170777.
2
LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.长链非编码 RNA FALEC 通过调控 Wnt/β-连环蛋白信号通路促进 PTC 细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4361-4367. doi: 10.26355/eurrev_202004_21017.
3
LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.长链非编码RNA PTCSC3/微小RNA-574-5p通过Wnt/β-连环蛋白信号通路调控甲状腺乳头状癌的细胞增殖和迁移
J Cell Biochem. 2017 Dec;118(12):4745-4752. doi: 10.1002/jcb.26142. Epub 2017 Jun 22.
4
LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.长链非编码 RNA HOTTIP 通过调节 miR-637 促进甲状腺乳头状癌细胞的增殖、侵袭和迁移。
Int J Biochem Cell Biol. 2018 May;98:1-9. doi: 10.1016/j.biocel.2018.02.013. Epub 2018 Feb 21.
5
Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.新型长链非编码 RNA AK023507 通过 β-连环蛋白/Wnt 信号通路抑制甲状腺乳头状癌细胞的转移和增殖。
Biochem Biophys Res Commun. 2023 May 7;655:104-109. doi: 10.1016/j.bbrc.2023.03.033. Epub 2023 Mar 14.
6
LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.长链非编码 RNA RGMB-AS1 受 E2F1 激活,促进甲状腺乳头状癌的细胞增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2018 Apr;22(7):1979-1986. doi: 10.26355/eurrev_201804_14725.
7
ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.ETS 样蛋白 ELK1 诱导的长链非编码 RNA LINC01638 通过 Wnt/β-连环蛋白信号通路调节 Axin2 加速甲状腺乳头状癌的进展。
Bioengineered. 2021 Dec;12(1):3873-3885. doi: 10.1080/21655979.2021.1935404.
8
Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.转化生长因子β1(TGF-β1)上调长链非编码 RNA-ATB 促进甲状腺乳头状癌细胞的迁移和侵袭。
Med Sci Monit. 2018 Jul 25;24:5152-5158. doi: 10.12659/MSM.909420.
9
Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.长链非编码RNA甲状腺乳头状癌易感候选基因3(PTCSC3)通过抑制Wnt/β-连环蛋白信号通路抑制胶质瘤细胞的增殖和侵袭。
BMC Neurol. 2017 Feb 10;17(1):30. doi: 10.1186/s12883-017-0813-6.
10
Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.长链非编码 RNA SNHG12 的表达增加预示着鼻咽癌预后不良,并通过调节 Notch 信号通路调节细胞增殖和转移。
Cancer Biomark. 2018;23(4):603-613. doi: 10.3233/CBM-181873.

引用本文的文献

1
Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway.钠/碘同向转运体过表达通过抑制β-连环蛋白/淋巴样增强因子1信号通路在抑制甲状腺癌细胞侵袭和维持干细胞特性中的作用
Heliyon. 2024 Mar 14;10(6):e27840. doi: 10.1016/j.heliyon.2024.e27840. eCollection 2024 Mar 30.
2
Therapeutic strategies to improve liver regeneration after hepatectomy.肝切除术后促进肝脏再生的治疗策略。
Exp Biol Med (Maywood). 2023 Aug;248(15):1313-1318. doi: 10.1177/15353702231191195. Epub 2023 Oct 3.
3
Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer.
基于ceRNA网络的甲状腺癌非编码RNA相关预后生物标志物的鉴定
Front Genet. 2023 Apr 20;14:1157438. doi: 10.3389/fgene.2023.1157438. eCollection 2023.
4
A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma.一种长链非编码RNA-免疫检查点相关基因特征可预测前列腺腺癌的无转移生存期。
Transl Androl Urol. 2022 Dec;11(12):1691-1705. doi: 10.21037/tau-22-711.
5
LINC01426 Triggers Growth and Metastasis of Lung Adenocarcinoma as a Prognostic Indicator.LINC01426 可作为一种预后指标,触发肺腺癌的生长和转移。
Biomed Res Int. 2022 May 17;2022:6175053. doi: 10.1155/2022/6175053. eCollection 2022.
6
The Long Non-Coding RNA as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms.长链非编码RNA通过表观遗传机制作为卵巢癌中顺铂耐药的介质。
Cancers (Basel). 2022 Mar 25;14(7):1664. doi: 10.3390/cancers14071664.
7
LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.长链非编码 RNA CALML3-AS1 通过海绵吸附 miR-20a-5p/RBM38 轴抑制甲状腺乳头状癌细胞的进展。
BMC Cancer. 2022 Mar 29;22(1):344. doi: 10.1186/s12885-022-09360-3.
8
Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.长链非编码 RNA LIFR-AS1 通过 miR-31-5p/SIDT2 轴抑制甲状腺乳头状癌细胞的增殖、血管生成、迁移和侵袭。
Cell Cycle. 2021 Dec;20(24):2619-2637. doi: 10.1080/15384101.2021.1995129. Epub 2021 Nov 16.
9
The Emerging Landscapes of Long Noncoding RNA in Thyroid Carcinoma: Biological Functions and Clinical Significance.甲状腺癌中长链非编码RNA的新前景:生物学功能及临床意义
Front Oncol. 2021 Aug 10;11:706011. doi: 10.3389/fonc.2021.706011. eCollection 2021.
10
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells.长链非编码 RNA 作为肿瘤细胞中多柔比星耐药的关键调控因子。
Cell Mol Biol Lett. 2021 Aug 23;26(1):39. doi: 10.1186/s11658-021-00282-9.